What Euclidean Capital LLC reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 1825034 · Filed Aug 14, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
VANGUARD INTL EQUITY INDEX FALLWRLD EX US | 3.2M | ±0% | $271.6M | 61.8% |
VANGUARD INDEX FDSVALUE ETF | 520K | ±0% | $113.3M | 25.8% |
ISHARES TRMSCI INDIA ETF | 369.6K | ±0% | $18.3M | 4.2% |
| 989.4K |
| ±0% |
| $10.7M |
| 2.4% |
TMSTeamshares Inc | 1.1M | New | $9M | 2.1% |
FHTXFoghorn Therapeutics Inc. | 1.6M | ±0% | $7.7M | 1.7% |
PMVPPMV Pharmaceuticals, Inc. | 2.6M | ±0% | $3.5M | 0.8% |
ALECAlector, Inc. | 1.3M | ±0% | $2.6M | 0.6% |
SRZNSurrozen, Inc. | 87.7K | ±0% | $2.3M | 0.5% |
TNYATenaya Therapeutics, Inc. | 1M | ±0% | $750.7K | 0.2% |
SRZNWSurrozen, Inc. | 170.8K | ±0% | $2.8K | 0.1% |
